Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya...

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

"Nautilus Biotechnology has entered into a definitive merger agreement with Arya Sciences Acquisition Corp III (Nasdaq: ARYA). Upon closing, the combined company is expected to be listed on Nasdaq under the ticker symbol “NAUT”

Nautilus Biotechnology is expected to receive $350 million in proceeds through the business combination, including a $200 million fully committed PIPE led by Perceptive Advisors and other top-tier healthcare investors

The business combination is expected to be completed in the second quarter of 2021.."

020821 Next-Gen Proteomics Company Nauti

.

Download • 322KB